John C. Lechleiter
2009
In 2009, John C. Lechleiter earned a total compensation of $20.9M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 45% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,553,125 |
|---|---|
| Non-Equity Incentive Plan | $3,551,100 |
| Salary | $1,483,333 |
| Stock Awards | $11,250,000 |
| Other | $90,091 |
| Total | $20,927,649 |
Lechleiter received $11.3M in stock awards, accounting for 54% of the total pay in 2009.
Lechleiter also received $4.6M of change in pension value and nonqualified deferred compensation earnings, $3.6M in non-equity incentive plan, $1.5M in salary and $90.1K in other compensation.
Rankings
In 2009, John C. Lechleiter's compensation ranked 44th out of 9,885 executives tracked by ExecPay. In other words, Lechleiter earned more than 99.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 44 out of 9,885 | 100th |
Division Manufacturing | 13 out of 3,690 | 100th |
Major group Chemicals And Allied Products | 7 out of 871 | 99th |
Industry group Drugs | 7 out of 643 | 99th |
Industry Pharmaceutical Preparations | 7 out of 446 | 98th |
Source: SEC filing on March 5, 2012.
Lechleiter's colleagues
We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2009.
2009
Steven Paul
Lilly Eli & Co
Executive Vice President, Science and Technology and President, Lilly Research Laboratories
2009
Bryce Carmine
Lilly Eli & Co
Retired Executive Vice President and President, Lilly Bio-Medicines
2009
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2009
Robert Armitage
Lilly Eli & Co